| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/16/1998 | WO1998030592A1 Novel epithelial tissue targeting agent |
| 07/16/1998 | WO1998030589A2 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | WO1998030586A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 07/16/1998 | WO1998030584A2 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | WO1998030566A1 Cyclic sulfone derivatives |
| 07/16/1998 | WO1998030558A2 Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 07/16/1998 | WO1998030556A1 Novel benzofuranone derivatives and process for producing the same |
| 07/16/1998 | WO1998030553A1 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| 07/16/1998 | WO1998030551A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNFα SECRETION |
| 07/16/1998 | WO1998030550A1 2,4-diaminopyrimidine compounds as anti-cancer agents |
| 07/16/1998 | WO1998030542A1 Vitronectin receptor antagonists |
| 07/16/1998 | WO1998030541A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion |
| 07/16/1998 | WO1998030247A1 A method and composition for cancer treatment by enzymatic conversion of soluble radioactive toxic agents |
| 07/16/1998 | WO1998030242A2 Photochemotherapeutic compositions |
| 07/16/1998 | WO1998030223A1 Cytokine related treatments of disease |
| 07/16/1998 | WO1998030190A2 Colon cancer kh-1 and n3 antigens |
| 07/16/1998 | WO1998016202A3 Fusogenic liposome composition and method |
| 07/16/1998 | WO1998014576A3 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | CA2278158A1 Cytokine related treatments of disease |
| 07/16/1998 | CA2277910A1 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 07/16/1998 | CA2277867A1 Colon cancer kh-1 and n3 antigens |
| 07/16/1998 | CA2277105A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion |
| 07/16/1998 | CA2277084A1 Human chloride channel protein (hccp) |
| 07/16/1998 | CA2276738A1 Vitronectin receptor antagonists |
| 07/16/1998 | CA2276483A1 Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof |
| 07/16/1998 | CA2276088A1 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | CA2276063A1 Secreted proteins and polynucleotides encoding them |
| 07/16/1998 | CA2276046A1 Novel epithelial tissue targeting agent |
| 07/16/1998 | CA2275886A1 Assay of histidine decarboxylase to detect cancer |
| 07/16/1998 | CA2275659A1 Photochemotherapeutic compositions |
| 07/16/1998 | CA2275566A1 2,4-diaminopyrimidine compounds as anti-cancer agents |
| 07/15/1998 | EP0853125A2 cDNA clone HNFJD15 that encodes a human 7-transmembrane receptor |
| 07/15/1998 | EP0853084A2 Substituted purine derivatives as vitronectin receptor antagonists |
| 07/15/1998 | EP0853083A1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof |
| 07/15/1998 | EP0852618A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 07/15/1998 | EP0852587A2 Synthetic peptides that inhibit il-6 activity |
| 07/15/1998 | EP0852500A1 Modified ether glyceroglycolipids |
| 07/15/1998 | EP0852467A1 Cancer chemoprotective food products |
| 07/15/1998 | CN1187821A Rapamycin derivatives |
| 07/15/1998 | CN1187769A Lactacystin analogs |
| 07/15/1998 | CN1187490A 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 07/15/1998 | CN1187351A Medicine for curing mastosis |
| 07/15/1998 | CN1039126C Tachiquinine antagonist tricyclic compounds and pharmaceutical compositions containing such compounds |
| 07/15/1998 | CN1039123C Process for preparing 3'-aziridino-anthracycline derivatives and its use |
| 07/14/1998 | US5780648 Benzothiophene compounds, and uses formulations thereof |
| 07/14/1998 | US5780596 Isolated binding protein used in detection of malignant cell types |
| 07/14/1998 | US5780592 Transplant, antitumor |
| 07/14/1998 | US5780588 Elucidation and synthesis of selected pentapeptides |
| 07/14/1998 | US5780510 2,4-disulfo phenyl butyl nitrone, its salts and their use as pharmaceuticals |
| 07/14/1998 | US5780508 Pharmacological preparations comprising a cystine derivative |
| 07/14/1998 | US5780496 Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions |
| 07/14/1998 | US5780472 Piperazine derivatives and methods for the preparation thereof and compositions containing the same |
| 07/14/1998 | US5780462 Methoxypoly(ethylene glycol) esters of rapamycin |
| 07/14/1998 | US5780461 Therapeutic treatment of cancer with Protein Kinase C inhibitors |
| 07/14/1998 | US5780455 Nonsettling acidic isotonic aqueous solution comprising sodium citrate, citric acid and sodium chloride |
| 07/14/1998 | US5780454 Boronic ester and acid compounds |
| 07/14/1998 | US5780033 Use of autoantibodies for tumor therapy and prophylaxis |
| 07/14/1998 | US5780032 Method of using monoclonal antibodies to cytokeratin fragments |
| 07/14/1998 | CA1339954C Dogs - and horse - interferones |
| 07/09/1998 | WO1998029555A2 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 07/09/1998 | WO1998029548A1 Human mage-like protein |
| 07/09/1998 | WO1998029452A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use |
| 07/09/1998 | WO1998029404A1 Benzopyran derivative originating in propolis |
| 07/09/1998 | WO1998029390A1 Farnesyl transferase inhibitors |
| 07/09/1998 | WO1998029123A1 Method of treating prostatic diseases using active vitamin d analogues |
| 07/09/1998 | WO1998029120A1 Treatment of liposarcomas using a combination of thiazolidinediones and retinoid x receptor selective agonists |
| 07/09/1998 | WO1998029119A1 Inhibitors of farnesyl-protein transferase |
| 07/09/1998 | WO1998029113A1 Treatment of disease states which result from neoplastic cell proliferation using ppar-gamma activators and compositions useful therefor |
| 07/09/1998 | WO1998029108A2 Compositions and methods for restoring a normal pattern of imprinting to cells |
| 07/09/1998 | WO1998029105A2 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations |
| 07/09/1998 | WO1998028980A1 Inhibitors of farnesyl-protein transferase |
| 07/09/1998 | CA2605707A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/09/1998 | CA2276465A1 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations |
| 07/09/1998 | CA2276288A1 Treatment of disease states which result from neoplastic cell proliferation using ppar-gamma activators and compositions useful therefor |
| 07/09/1998 | CA2276150A1 Inhibitors of farnesyl-protein transferase |
| 07/09/1998 | CA2276081A1 Inhibitors of farnesyl-protein transferase |
| 07/09/1998 | CA2275975A1 Human mage-like protein |
| 07/09/1998 | CA2275943A1 Farnesyl transferase inhibitors |
| 07/08/1998 | EP0851925A1 Human growth hormone variants |
| 07/08/1998 | EP0851922A1 Cyclin depenpent kinase binding compounds |
| 07/08/1998 | EP0851920A1 Variants of vascular endothelial cell growth factor, their uses, and processes for their porduction |
| 07/08/1998 | EP0851875A2 Dna sequences and secreted proteins encoded thereby |
| 07/08/1998 | EP0851871A1 Inhibition of tumor growth |
| 07/08/1998 | EP0851869A1 Breast specific genes and proteins |
| 07/08/1998 | EP0851866A1 Therapeutic compounds |
| 07/08/1998 | EP0851857A1 Inhibitors of tumor necrosis factor alpha |
| 07/08/1998 | EP0851855A1 Acylated derivatives of melatonin and its analogues, useful as medicaments |
| 07/08/1998 | EP0851769A1 Gene therapy using ovine adenoviral vectors |
| 07/08/1998 | EP0851765A1 Therapeutic and prophylactic methods using heat shock proteins |
| 07/08/1998 | EP0820283A4 Lactacystin analogs |
| 07/08/1998 | EP0815096A4 Cephalomannine epoxide, its analogues and a method for preparing the same |
| 07/08/1998 | EP0788388A4 Device for aerosolized delivery of peptide drugs |
| 07/08/1998 | EP0754035A4 Carotenoid agent for inhibiting the conversion of epithelial cells to tumours |
| 07/08/1998 | EP0632805B1 Melamine derivatives for use in the treatment of cancer |
| 07/08/1998 | EP0619841B1 T-cadherin adhesion molecule |
| 07/08/1998 | EP0504291B1 Novel proteins with oncostatin m activity and process for their preparation |
| 07/08/1998 | EP0398955B1 Diagnosis of retinoblastoma |
| 07/08/1998 | CN1187199A Novel dolastatin derivatives, their preparation and use |
| 07/08/1998 | CN1187198A Novel dolastatin derivatives, their preparation and use |
| 07/08/1998 | CN1187129A Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |